| 000 | 01934cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030731.0 | ||
| 008 | 121231s2012 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.28.M.Sc.2012.Do.D | ||
| 100 | 0 | _aDoaa Meshref Osman | |
| 245 | 1 | 0 |
_aDiastolic dysfunction in children with systemic lupus erythematosus with and without antiphospholipid antibodies / _cDoaa Meshref Osman ; Supervised Mortada Hassan Elshabrawi , Samia Salah Eldin Mahmoud , Rasha Ibrahim Ammar |
| 246 | 1 | 5 | _aدراسة عن الخلل الانبساطى بوظائف القلب لأطفال الذئبة الحمراء المصاحبة و الغير مصاحبة للأجسام المضادة للدهون الفوسفاتية |
| 260 |
_aCairo : _bDoaa Meshref Osman , _c2012 |
||
| 300 |
_a159 P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Pediatrics | ||
| 520 | _aCardiovascular disease is a major cause of death in patients with systemic lupus erythematosus (SLE), especially during the late phase of the disease. Ventricular diastolic dysfunction is considered one of its common findings and may preceed systolic dysfunction with overt morbidity and mortality. There is also some evidence about the association of antiphospholipid (aPL) antibodies with ventricular diastolic dysfunction in children with SLE | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aDiastolic | |
| 653 | 4 | _aVentricular diastolic dysfunction | |
| 653 | 4 | _aVentricular function | |
| 700 | 0 |
_aMortada Hassan Elshabrawi , _eSupervisor |
|
| 700 | 0 |
_aRasha Ibrahim Ammar , _eSupervisor |
|
| 700 | 0 |
_aSamia Salah Eldin Mahmoud , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c40819 _d40819 |
||